25 Jan Roadmap for CMs
Posted at 11:56h
in
This document has been prepared to serve as guidance to stakeholders regarding the regulation pathway of Category D medicines ( complementary medicines registration. It represe ) for which claims of safety, quality and efficacy and which may be called up for nts the South African Health Products Regulatory Authority’s current thinking on the appropriate assurance of safety, quality and efficacy of CMs and the intention of the Authority over the described period of time
2021 Dec
Download latest version
Document Number:
7.02
Version:
2
Date Updated:
08/12/2021
File Type:
pdf
Category:
Guideline